MedTrace Logo

Home Blood Pressure Monitoring to Improve Hypertension

NCT05604040 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2024-11-25

No results posted yet for this study

Summary

The goal of this single group pre-post-study is to test the possibility of self-monitoring with shared medical appointments program for lifestyle education in improving blood pressure (BP) of patients with uncontrolled hypertension.

The main questions it aims to address is:

1. To assess if patients with uncontrolled hypertension and their physicians will be interested in trying a program that includes self-monitoring with 6-week support for lifestyle changes and coping skills to improve BP and hypertension control.
2. To assess if patients with uncontrolled hypertension can safely participate in a program that includes self-monitoring with 6-week support for lifestyle changes and coping skills to improve their BP and ability to self-manage hypertension

Participants will:

* Send self-reports of their home BPs, diet, physical activity and emotions
* Attend 6-week education program of lifestyle changes and coping skills delivered by physicians, holistic psychotherapists and yoga therapists.

Conditions

Interventions

BEHAVIORAL

Lifestyle Modifications

Home BP monitoring with self-monitoring of emotions, diet, physical activity, with shared medical appointment program for lifestyle changes and coping skills

Sponsors & Collaborators

  • Cleveland State University

    collaborator OTHER

  • MetroHealth System, Ohio

    collaborator OTHER

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Sonal J Patil, MD, MSPH · The Cleveland Clinic

  • Irina Todorov, MD · The Cleveland Clinic

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-14
Primary Completion
2023-06-16
Completion
2024-06-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05604040 on ClinicalTrials.gov